1. Home
  2. CFFI vs CCCC Comparison

CFFI vs CCCC Comparison

Compare CFFI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C&F Financial Corporation

CFFI

C&F Financial Corporation

N/A

Current Price

$71.19

Market Cap

218.0M

Sector

Finance

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$1.92

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFI
CCCC
Founded
1927
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.0M
240.3M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
CFFI
CCCC
Price
$71.19
$1.92
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.25
AVG Volume (30 Days)
6.2K
1.9M
Earning Date
01-27-2026
11-06-2025
Dividend Yield
2.53%
N/A
EPS Growth
43.03
N/A
EPS
8.09
N/A
Revenue
$125,432,000.00
$30,108,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.97
N/A
Revenue Growth
9.28
N/A
52 Week Low
$53.14
$1.09
52 Week High
$89.90
$4.26

Technical Indicators

Market Signals
Indicator
CFFI
CCCC
Relative Strength Index (RSI) 51.85 34.02
Support Level $67.83 $1.93
Resistance Level $73.16 $2.13
Average True Range (ATR) 2.26 0.13
MACD -0.43 -0.03
Stochastic Oscillator 41.06 2.53

Price Performance

Historical Comparison
CFFI
CCCC

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: